NFAT2 mediates high glucose-induced glomerular podocyte apoptosis through increased Bax expression

Experimental Cell Research

Volumn 319, Issue 7, 2013, Pages 992-1000

  Li, Ruizhao ^a   Zhang, Li ^a,b   Shi, Wei ^a   Zhang, Bin ^a   Liang, Xinling ^a   Liu, Shuangxin ^a   Wang, Wenjian ^a  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Activate nuclear factor of activated T cells; Apoptosis; Bax; High glucose; Podocyte

Indexed keywords

CYCLOSPORIN A; MESSENGER RNA; PROTEIN BAX; TRANSCRIPTION FACTOR NFAT;

ANIMAL CELL; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CELL IMMORTALIZATION; ENZYME ACTIVATION; HYPERGLYCEMIA; IMMUNOFLUORESCENCE TEST; MOUSE; NONHUMAN; PODOCYTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; WESTERN BLOTTING;

EID: 84874985656     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.01.007     Document Type: Article

References (37)

1. Collins A.J., Foley R.N., Chavers B., Gilbertson D., Herzog C., Johansen K., Kasiske B., Kutner N., Liu P.W., Guo H., Gustafson S., Heubner B., Lamb K., Li S., Li S., Peng Y., Qiu Y., Roberts T., Skeans M., Snyder J., Solid C., Thompson B., Wang C., Weinhandl E., Zaun D., Arko C., Chen S.C., Daniels F., Ebben J., Frazier E., Hanzlik C., Johnson R., Sheets D., Wang X., Forrest B., Constantini E., Everson S., Eggers P., Agodoa L. United States renal data system 2011 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Am. J. Kidney Dis. 2012, 59(A7):e1-e420.
2. Remuzzi G., Schieppati A., Ruggenenti P. Clinical practice. Nephropathy in patients with type 2 diabetes. N. Engl. J. Med. 2002, 346:1145-1151.
3. Parving H.H., Hovind P., Rossing K., Andersen S. Evolving strategies for renoprotection: diabetic nephropathy. Curr. Opin. Nephrol. Hypertens. 2001, 10:515-522.
4. Vejakama P., Thakkinstian A., Lertrattananon D., Ingsathit A., Ngarmukos C., Attia J. Reno-protective effects of renin-angiotensin system blockade in type 2 diabetic patients: a systematic review and network meta-analysis. Diabetologia 2012, 55:566-578.
5. Wolf G., Chen S., Ziyadeh F.N. From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes 2005, 54:1626-1634.
6. Fogo A.B. The targeted podocyte. J. Clin. Invest. 2011, 121:2142-2145.
7. Pagtalunan M.E., Miller P.L., Jumping-Eagle S., Nelson R.G., Myers B.D., Rennke H.G., Coplon N.S., Sun L., Meyer T.W. Podocyte loss and progressive glomerular injury in type II diabetes. J. Clin. Invest. 1997, 99:342-348.
8. White K.E., Bilous R.W., Marshall S.M., El N.M., Remuzzi G., Piras G., De Cosmo S., Viberti G. Podocyte number in normotensive type 1 diabetic patients with albuminuria. Diabetes 2002, 51:3083-3089.
9. Lee S.C., Han S.H., Li J.J., Lee S.H., Jung D.S., Kwak S.J., Kim S.H., Kim D.K., Yoo T.H., Kim J.H., Chang S.H., Han D.S., Kang S.W. Induction of heme oxygenase-1 protects against podocyte apoptosis under diabetic conditions. Kidney Int. 2009, 76:838-848.
10. Verzola D., Gandolfo M.T., Ferrario F., Rastaldi M.P., Villaggio B., Gianiorio F., Giannoni M., Rimoldi L., Lauria F., Miji M., Deferrari G., Garibotto G. Apoptosis in the kidneys of patients with type II diabetic nephropathy. Kidney Int. 2007, 72:1262-1272.
11. Susztak K., Raff A.C., Schiffer M., Bottinger E.P. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 2006, 55:225-233.
12. Rao A., Luo C., Hogan P.G. Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 1997, 15:707-747.
13. Kiani A., Rao A., Aramburu J. Manipulating immune responses with immunosuppressive agents that target NFAT. Immunity 2000, 12:359-372.
14. Benedito A.B., Lehtinen M., Massol R., Lopes U.G., Kirchhausen T., Rao A., Bonni A. The transcription factor NFAT3 mediates neuronal survival. J. Biol. Chem. 2005, 280:2818-2825.
15. Chai W.R., Wang Q., Gao H.B. NFAT2 is implicated in corticosterone-induced rat Leydig cell apoptosis. Asian J. Androl. 2007, 9:623-633.
16. Nilsson J., Nilsson L.M., Chen Y.W., Molkentin J.D., Erlinge D., Gomez M.F. High glucose activates nuclear factor of activated T cells in native vascular smooth muscle. Arterioscler. Thromb. Vasc. Biol. 2006, 26:794-800.
17. Ranger A.M., Grusby M.J., Hodge M.R., Gravallese E.M., de la Brousse F.C., Hoey T., Mickanin C., Baldwin H.S., Glimcher L.H. The transcription factor NF-ATc is essential for cardiac valve formation. Nature 1998, 392:186-190.
18. Chin E.R., Olson E.N., Richardson J.A., Yang Q., Humphries C., Shelton J.M., Wu H., Zhu W., Bassel-Duby R., Williams R.S. A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. Genes Dev. 1998, 12:2499-2509.
19. Larrieu D., Thiébaud P., Duplàa C., Sibon I., Thézé N., Lamazière J.M. Activation of the Ca(2+)/calcineurin/NFAT2 pathway controls smooth muscle cell differentiation. Exp. Cell Res. 2005, 310:166-175.
20. Graef I.A., Chen F., Chen L., Kuo A., Crabtree G.R. Signals transduced by Ca(2+)/calcineurin and NFATc3/c4 pattern the developing vasculature. Cell 2001, 105:863-875.
21. Molkentin J.D., Lu J.R., Antos C.L., Markham B., Richardson J., Robbins J., Grant S.R., Olson E.N. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 1998, 93:215-228.
22. Vyas D.R., Spangenburg E.E., Abraha T.W., Childs T.E., Booth F.W. GSK-3beta negatively regulates skeletal myotube hypertrophy. Am. J. Physiol. Cell. Physiol. 2002, 283:C545-lC551.
23. Lawrence M.C., Bhatt H.S., Easom R.A. NFAT regulates insulin gene promoter activity in response to synergistic pathways induced by glucose and glucagon-like peptide-1. Diabetes 2002, 51:691-698.
24. Wisniewska M., Stanczyk M., Grzelakowska-Sztabert B., Kaminska B. Nuclear factor of activated T cells (NFAT) is a possible target for dexamethasone in thymocyte apoptosis. Cell. Biol. Int. 1997, 21:127-132.
25. Pu W.T., Ma Q., Izumo S. NFAT transcription factors are critical survival factors that inhibit cardiomyocyte apoptosis during phenylephrine stimulation in vitro. Circ. Res. 2003, 92:725-731.
26. Wang Y., Jarad G., Tripathi P., Pan M., Cunningham J., Martin D.R., Liapis H., Miner J.H., Chen F. Activation of NFAT signaling in podocytes causes glomerulosclerosis. J. Am. Soc. Nephrol. 2010, 21:1657-1666.
27. Wang L., Chang J.H., Paik S.Y., Tang Y., Eisner W., Spurney R.F. Calcineurin (CN) activation promotes apoptosis of glomerular podocytes both in vitro and in vivo. Mol. Endocrinol. 2011, 25:1376-1386.
28. Mundel P., Reiser J., Zuniga M.B.A., Pavenstadt H., Davidson G.R., Kriz W., Zeller R. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp. Cell Res. 1997, 236:248-258.
29. Aramburu J., Garcia-Cozar F., Raghavan A., Okamura H., Rao A., Hogan P.G. Selective inhibition of NFAT activation by a peptide spanning the calcineurin targeting site of NFAT. Mol. Cell 1998, 1:627-637.
30. Vogel M.W. Cell death, Bcl-2, Bax, and the cerebellum. Cerebellum 2002, 1:277-287.
31. Reed J.C. Proapoptotic multidomain Bcl-2/Bax-family proteins: mechanisms, physiological roles, and therapeutic opportunities. Cell Death Differ. 2006, 13:1378-1386.
32. Kriz W., Gretz N., Lemley K.V. Progression of glomerular diseases: is the podocyte the culprit?. Kidney Int. 1998, 54:687-697.
33. Garg P., Holzman L.B. Podocytes: Gaining a foothold. Exp. Cell Res. 2012, 318:955-963.
34. Eid A.A., Gorin Y., Fagg B.M., Maalouf R., Barnes J.L., Block K., Abboud H.E. Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases. Diabetes 2009, 58:1201-1211.
35. Siu B., Saha J., Smoyer W.E., Sullivan K.A., Brosius F.R. Reduction in podocyte density as a pathologic feature in early diabetic nephropathy in rodents: prevention by lipoic acid treatment. BMC Nephrol. 2006, 7:6.
36. Schlondorff J., Del C.D., Carrasquillo R., Lacey V., Pollak M.R. TRPC6 mutations associated with focal segmental glomerulosclerosis cause constitutive activation of NFAT-dependent transcription. Am. J. Physiol. Cell Physiol. 2009, 296:C558-C569.
37. Nijenhuis T., Sloan A.J., Hoenderop J.G., Flesche J., van Goor H., Kistler A.D., Bakker M., Bindels R.J., de Boer R.A., Moller C.C., Hamming I., Navis G., Wetzels J.F., Berden J.H., Reiser J., Faul C., van der Vlag J. Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway. Am. J. Pathol. 2011, 179:1719-1732.